CLINICAL PERSPECTIVES OF BETA-CARBOLINES FROM 1ST STUDIES IN HUMANS

被引：18

作者：

DOROW, R

DUKA, T

HOLLER, L

SAUERBREY, N

机构：

来源：

关键词：

D O I：

10.1016/0361-9230(87)90100-6

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：319 / 326

页数：8

共 47 条

[1] BADDELEY AD, 1968, PSYCHON SCI, V10, P341
[2] BENAVIDES J, 1984, NEUROPHARMACOLOGY, V10, P1129
[3] CGS-9896 - A NONBENZODIAZEPINE, NONSEDATING POTENTIAL ANXIOLYTIC
BENNETT, DA
PETRACK, B
[J]. DRUG DEVELOPMENT RESEARCH, 1984, 4 (01) : 75 - 82
[4] BERNARD PS, 1985, J PHARMACOL EXP THER, V235, P98
[5] BIECK PR, 1984, CLIN NEUROPHARMAC S1, V7, P674
[6] CGS-8216 - RECEPTOR-BINDING CHARACTERISTICS OF A POTENT BENZODIAZEPINE ANTAGONIST
CZERNIK, AJ
PETRACK, B
KALINSKY, HJ
PSYCHOYOS, S
CASH, WD
TSAI, C
RINEHART, RK
GRANAT, FR
LOVELL, RA
BRUNDISH, DE
WADE, R
[J]. LIFE SCIENCES, 1982, 30 (04) : 363 - 372
[7] DARRAGH A, 1981, LANCET, V2, P8
[8] Dorow R, 1987, Psychopharmacol Ser, V3, P37
[9] DOROW R, 1987, IN PRESS PSYCHOPHARM
[10] DOROW R, 1986, GABAERGIC TRANSMISSI, P221